# Sugammadex

NDC: 67457-970
Generic name: Sugammadex
Labeler / Manufacturer: Mylan Institutional LLC
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: INJECTION, SOLUTION
Routes: INTRAVENOUS
Marketing started: 20260728

FDA application: ANDA213915

## Active ingredients

- SUGAMMADEX SODIUM: 100 mg/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"67457-970"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=67457-970
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=eb84def8-933b-4eba-b81f-30d40b1e3d8d